These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34375393)

  • 41. Is Testosterone Replacement Therapy in Older Men Effective and Safe?
    Yabluchanskiy A; Tsitouras PD
    Drugs Aging; 2019 Nov; 36(11):981-989. PubMed ID: 31595418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale.
    Basaria S
    Endocr Pract; 2013; 19(5):853-63. PubMed ID: 24014017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement.
    Kim ED; McCullough A; Kaminetsky J
    BJU Int; 2016 Apr; 117(4):677-85. PubMed ID: 26496621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
    Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
    Dimitriadis GK; Randeva HS; Aftab S; Ali A; Hattersley JG; Pandey S; Grammatopoulos DK; Valsamakis G; Mastorakos G; Jones TH; Barber TM
    Endocrine; 2018 Apr; 60(1):175-184. PubMed ID: 29396841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognition is not modified by large but temporary changes in sex hormones in men.
    Young LA; Neiss MB; Samuels MH; Roselli CE; Janowsky JS
    J Clin Endocrinol Metab; 2010 Jan; 95(1):280-8. PubMed ID: 19880786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment.
    Bain J; Brock G; Kuzmarov I; For The International Consulting Group
    J Sex Med; 2007 May; 4(3):558-566. PubMed ID: 17498097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
    Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
    J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of physiotherapy in addition to testosterone replacement therapy on the efficiency of the motor system in men with hypogonadism.
    Bacevičienė R; Valonytė L; Ceponis J
    Medicina (Kaunas); 2013; 49(2):71-7. PubMed ID: 23888342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testosterone effects on cognition in health and disease.
    Cherrier M
    Front Horm Res; 2009; 37():150-162. PubMed ID: 19011295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone replacement in older men and women.
    Morley JE
    J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Testosterone replacement treatment in older people with and without co-morbidities].
    Zitzmann M
    Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia.
    Artz AS; Stephens-Shields AJ; Bhasin S; Ellenberg SS; Cohen HJ; Snyder PJ
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3396-403. PubMed ID: 32785689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.